Our meetups are built for data enthusiasts
Biostatisticians and statistical programmers
Data scientists and computational scientists
Clinical development and regulatory professionals
Leaders interested in the future of analytics in biotech and pharma
Academic and industry collaborators
What we explore
Modern data science in biotech and pharma
Cutting-edge trends in data science for biotech and pharmaceutical companies, including scalable analytics, cloud-enabled workflows, decision support, reproducible research, and AI-enabled scientific research and computing.Clinical trial innovation
Novel endpoints, patient selection, safety monitoring, pediatric development, rare disease settings, and new ways to design and analyze trials.R, Python, and open-source analytics
Practical use of modern tools for analysis, visualization, interactivity, collaboration, and production-quality workflows.Real-world data and evidence
Applications, standards, curation challenges, and regulatory relevance of RWD and RWE in development programs.Regulatory and submission trends
Topics such as evolving submission expectations, interactive outputs, non-traditional workflows, and data standards.Digital health and diagnostics
Wearables, mobile health, digital pathology, liquid biopsy, ctDNA, privacy, and the growing role of digital tools in trials and care.Career development and leadership
Conversations on career growth, leadership, communication, cross-functional influence, and navigating evolving roles in biotech and pharma.Upskilling and professional growth
Opportunities to learn new tools, methods, and ways of working so members can stay current with advances in statistics, programming, data science, and scientific collaboration.
RANGE OF POTENTIAL TECHNICAL TOPICS THEMES
Use of modern data infrastructures and technologies to optimize clinical data collection, aggregation, access, monitoring, and analysis
Analysis solutions:
adaption of R and Python in pharma
interactive analyses via RMarkdown, RShiny, iPython
Data warehouse solutions (AWS Athena, Redshift)
Choice of cloud computing (e.g., AWS, Azure, Google cloud)
Data processing and ETL (AWS GLue, Matillion)
Data aggregation: new data types, processes and systems
Understanding challenges and opportunities in drug development
Patient selection and utilization
Development of novel endpoints
Monitoring and understanding safety data collection, analysis and interpretation
Impact of orphan disease status on planning for efficacy and safety targets and analyses
Clinical development for pediatrics indications
Considerations and examples in utilizing real world data
The use of RWD in regulatory submissions
Challenges and opportunities in utilizing RWD: the use of standards and curation, etc.
Regulatory trends and guidances with impact on data collection, analysis and interpretation
non-SAS based submission
Interactive tools for submission
Rolling submissions
Expedited approvals
RWD/RWE
CDISC
Software as device/therapy
Challenges and opportunities in new digital healthcare solutions
Wearables
Mobile health
Data privacy
Data ownership
Understanding novel diagnostics, and their impact to clinical trials and clinical practice
ctDNA
Digital pathology/CT
Liquid biopsies
COVID 19
Missing data and statistical challenges
Operational challenges
Regulatory challenges
Manuscript review
